 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
|||||||||
| Faculty Name and Research Interest | |
 |
Janet A. Amico, MD Role of oxytocin in stress, anxiety, and ingestive behaviors. |
 |
Jan H. Beumer, PharmD, PhD |
 |
Kim C. Coley, PharmD, FCCP Factors that impact beneficial and adverse clinical outcomes to medications under conditions of usual care. |
 |
Billy W. Day, PhD Design, synthesis, and mechanistic (pharmacological and proteomic) evaluation of drugs and carcinogens |
 |
Alexander Doemling, PhD Drug discovery for challenging targets (protein protein interactions, allosteric sites): design, synthesis, screening, cells, animals. |
 |
Kerry M. Empey, PharmD, PhD Our lab is interested in improving pulmonary infections in immunocompromised patients using immune modulating therapy. |
 |
Philip Empey, PharmD, PhD, BCPS |
 |
Tanya J. Fabian, PharmD, PhD Interaction between stress and mental and physical health; genetic vulnerability to depression; prevention strategies. |
 |
Maggie Folan, PhD |
 |
Robert B. Gibbs, PhD Effects of gonadal hormones on cholinergic neurons, brain aging, and cognition. |
 |
Barry Gold, PhD Design and characterization of DNA binding molecules. |
 |
Levent Kirisci, PhD Development of instruments utilized in substance abuse; item response theory; mixed modeling; structural equation modeling. |
 |
Yong Tae Kwon, PhD Physiological functions and molecular mechanisms of ubiquitin-dependent proteolysis in mammals. |
 |
Song Li, MD, PhD Drug and Gene Delivery, and Gene Regulation |
 |
Yong Li, PhD Structural and functional studies of nuclear receptors, structure-activity relationship and drug discovery |
 |
Dexi Liu, PhD Gene therapy and drug delivery systems. |
 |
Samuel M. Poloyac, PharmD, PhD Role of cytochrome P450 enzymes in the pathogenesis of neurotraumatic disease. |
 |
Lisa C. Rohan, PhD Design and development of drug delivery systems for STI/HIV prevention and gynecologic oncology applications. |
 |
Ralph E. Tarter, PhD Elucidating the interaction between biobehavioral and environmental factors underlying etiology of drug abuse and addiction. |
 |
Raman Venkataramanan, PhD Drug disposition in transplant patients; regulation of drug metabolism; drug metabolism and transport during pregnancy. |
 |
Regis R. Vollmer, PhD Neural control of thermoregulation and the role of oxytocin in ingestive behavior. |
 |
Peter Wipf, PhD Total synthesis of natural products, organometallic methodology, and medicinal chemistry. |
 |
Wen Xie, MD, PhD Orphan nuclear receptor-mediated gene regulation in drug metabolism and human diseases. |
 |
Xiangqun (Sean) Xie, PhD, MBA GPCR NMR structural proteomics and in-silico drug design/pharmacoinformatics virtual screening method development. |
 |
Jeffrey K. Yao, PhD, FACB Application of metabolomics in psychosis and therapeutic monitoring. |
 |
Michael A. Zemaitis, PhD Drug metabolism and analysis of drugs and metabolites in biological fluids. |
